For a PDF version, please click here
For new papers
- Cover letter
- Summary statement
- Supplementary material (as necessary)
- A Clinical Perspectives section for research articles
For revised papers
- As stated above for new papers
- Response to reviewer report
Requirements for main text
- Title (maximum 16 words)
- Names and addresses of all authors
- Name and email address of corresponding author
- Abstract (maximum 250 words)
- Summary statement (maximum 40 words) – written for a broad audience, highlighting the key finding of your study
- Short title (up to 75 characters)
- Keywords (3–6)
- Abbreviations list
- Full text of paper, to include: Introduction, Experimental/Materials and methods, Results, Discussion
- Declarations of interest
- Funding information
- Author contribution statement
- References (using the numbering Vancouver system)
- Tables with titles and legends (if applicable)
- Figures with titles and legends
On acceptance, you will be asked to provide a Word file of the main text and any tables, and electronic Figure files.
Figures – figures should be supplied as electronic files. Full instructions for preparation of your files will be provided on acceptance.
Research Papers - the normal form of publication, of approximately six to eight printed pages.
Reviews - normally commissioned, although non-commissioned reviews will be considered for publication. Prospective authors should contact firstname.lastname@example.org providing a short summary of the area they propose to cover.
Hypotheses - normally commissioned although non-commissioned hypotheses will be considered for publication.
(i) Colour figures
There is no charge for the use of colour in figures. Colour should only be used if it is essential to illustrate a particular scientific point.
(ii) Figure resolution
Figures should be provided in the following file formats and at the indicated resolution.
BLACK and WHITE (e.g. line diagrams, histograms) – as .tiff (or .eps) files at 600 dpi
GREYSCALE (e.g. gel images) – as .tiff (or .eps) files at 300 dpi
COLOUR – as .tiff (or .eps) files at 300 dpi
(iii) Image manipulation
Images will be checked for manipulation when a paper is accepted. The Editorial Board may request that authors supply the original data for comparison against the prepared figures. If authors are unable to comply with such a request, the acceptance of the paper may be withdrawn.
Portland Press endorses the guidelines given in the Instructions for Authors of the Journal of Cell Biology, from where the following is reproduced by kind permission of Rockefeller University Press:
No specific feature within an image may be enhanced, obscured, moved, removed or introduced. The grouping of images from different parts of the same gel, or from different gels, fields or exposures must be made explicit by the arrangement of the figure (i.e. using dividing lines) and in the text of the figure legend. Adjustments of brightness, contrast or colour balance are acceptable if they are applied to the whole image and as long as they do not obscure, eliminate or misrepresent any information present in the original, including backgrounds. Without any background information, it is not possible to see exactly how much of the original gel is actually shown. Non-linear adjustments (e.g. changes to gamma settings) must be disclosed in the figure legend.
Authors are encouraged to read the paper by M. Rossner and K.M. Yamada (2004) J. Cell Biol. 166, 11–15.
Authors may submit additional data (e.g. additional figures, large datasets, additional tables, movies, three-dimensional structures) as supplementary material to accompany their main paper.
For full details of the editorial style and conventions that Portland Press journals adhere to, please click here.
In-line equations should be typed as text. Displayed equations are retyped by our typesetter.
As far as possible authors should follow the recommendations of the Nomenclature Committee of IUBMB and the IUPAC–IUBMB Joint Commission on Biochemical Nomenclature (see http://www.chem.qmul.ac.uk/iubmb/).
The IUPAC recommendations on chemical nomenclature should be followed.
The recommendations of the latest edition of Enzyme Nomenclature (1992, ISBN 0 12 227165 3, Academic Press, San Diego; and its supplements) should be followed as far as possible. This includes the quoting of EC numbers.
Clinical Science encourages authors to use the symbols and nomenclature recommended by the HUGO Gene Nomenclature Committee which is responsible for approving and implementing unique human gene symbols and names, and works closely with the Mouse Genome Database and other organism databases. Considerable efforts are made to approve symbols acceptable to workers in the field, but sometimes it is not possible to use exactly what has previously appeared in the literature. In such cases the previously used symbols are listed as aliases for the approved nomenclature in the Human Genome Nomenclature Database and Entrez Gene to allow retrieval of all the information available for each gene.
Approved human gene symbols may be obtained before submission from the HUGO Gene Nomenclature Committee (HGNC), European Bioinformatics Institute (EMBL-EBI), Wellcome Trust Genome Campus, Hinxton, Cambridgeshire CB10 1SA, U.K.; fax: +44 (0)1223 494 468; email: email@example.com; http://www.genenames.org/
Approved mouse nomenclature may be obtained before submission from Lois Maltais, The Jackson Laboratory, Bar Harbor, ME 04609-0800, U.S.A.; tel: +1 207 288 6429; fax: +1 207 288 6132; email: firstname.lastname@example.org; http://www.informatics.jax.org/mgihome/nomen/.
(i) Animal experimentation
Experiments with animals should be performed in accordance with the legal requirements of the relevant local or national authority and a statement to this effect must be included in the paper. Procedures should be such that experimental animals do not suffer unnecessarily. The text of papers should include experimental details of the procedures and of anaesthetics used. For additional information on the reporting of work in animals, please see the ARRIVE Guidelines.
(ii) Human experimentation
Papers describing any experimental work with humans should include a statement that the research has been carried out in accordance with the Declaration of Helsinki (2013) of the World Medical Association, that the Ethical Committee of the Institution in which the work was performed has approved it, and that the subjects have given written informed consent to the work.
(iii) Scientific publication
Portland Press is a member of COPE (Committee on Publication Ethics) and endorses its guidelines, including the Code of Conduct for Editors, which are available at http://www.publicationethics.org/. Complaints against the Journal must be submitted in writing to the Chair of the Editorial Board; if a complaint is not resolved to the satisfaction of the complainant they have the option of referring the matter to COPE.
Authors may like to refer to the Ethical Guidelines to Publication of Chemical Research formulated by the American Chemical Society [see Biochemistry (1986) 25, 9A–10A].
Notwithstanding, the Editorial Board will not accept papers where the ethical aspects are, in the Editorial Board's opinion, open to doubt.
Portland Press believes that the Editorial Boards of its journals has a duty to protect the scientific record. Therefore it will always investigate fully any matter of apparent misconduct that it becomes aware of with respect to both published and unpublished papers, in conjunction with the institution where the work was performed or with funding bodies as appropriate.
Portland Press journals follow the guidelines published by COPE in respect of the retraction of articles.
Portland Press will not tolerate plagiarism in manuscripts submitted to its journals. Passages quoted or closely paraphrased from other authors (or from the submitting authors' own published work) must be identified as quotations or paraphrases, and the sources of the quoted or paraphrased material must be acknowledged. Use of unacknowledged sources will be construed as plagiarism. If any manuscript is found to contain plagiarized material the review process will be halted immediately.
Images will be checked for manipulation when a paper is accepted. The Editorial Board may request that authors supply the original data for comparison against the prepared figures. If authors are unable to comply with such a request, the acceptance of the paper may be withdrawn. The interpretation of this policy is in the hands of the Editorial Board, who judge whether each paper submitted is acceptable in terms of science and presentation.
Submission of a paper to the Portland Press journals implies that it has been approved by all of the named authors, that all persons entitled to authorship have been so named, that it reports unpublished work that is not under consideration for publication elsewhere in any language, that conflicts of interest are declared and that, if the paper is accepted for publication, the authors will grant the Biochemical Society an exclusive licence to publish the paper. Portland Press endorses the Vancouver Guidelines on authorship as defined in the International Committee of Medical Journal Editors' (ICMJE) Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals, namely that entitlement to authorship should be based on all of the following criteria: (1) substantial contributions to conception and design, or acquisition of data, or analysis and interpretation of data; (2) drafting the article or revising it for important intellectual content; (3) final approval of the version to be published; (4) agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. Acquisition of funding, collection of data, or general supervision of the research group, alone, does not justify authorship. All contributors who do not meet the criteria for authorship should be listed in the Acknowledgements. On acceptance, a paragraph outlining the contribution of each author to the study will be requested and published as part of the paper.
Please direct any correspondence to:
Portland Press Limited, Charles Darwin House, 12 Roger Street, London WC1N 2JU, U.K.
Tel: +44 (0)20 7685 2410
Fax: +44 (0)20 7685 2469